BioRestorative Therapies Inc (BRTX) — Cash Flow-to-Debt Ratio
BioRestorative Therapies Inc (BRTX) has a Cash Flow-to-Debt Ratio of -0.84x as of September 2025, meaning its operating cash flow of $-2.90 Million could theoretically repay -1% of its total liabilities ($3.44 Million) in one year. See BRTX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BioRestorative Therapies Inc Cash Flow-to-Debt Ratio (2010–2024)
Historical debt coverage capacity for BioRestorative Therapies Inc across 15 annual periods. Also explore BioRestorative Therapies Inc net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for BioRestorative Therapies Inc (2010–2024)
Year-by-year debt coverage analysis for BioRestorative Therapies Inc. For market capitalisation and broader financial context, see BRTX market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.20x | $-8.23 Million | $3.75 Million | ▲ +11.0% |
| 2023 | -2.47x | $-6.43 Million | $2.61 Million | ▼ -156.3% |
| 2022 | -0.96x | $-5.91 Million | $6.14 Million | ▲ +75.2% |
| 2021 | -3.89x | $-3.33 Million | $856.50K | ▼ -1023.9% |
| 2020 | -0.35x | $-1.96 Million | $5.68 Million | ▲ +28.8% |
| 2019 | -0.49x | $-6.92 Million | $14.24 Million | ▲ +6.4% |
| 2018 | -0.52x | $-5.10 Million | $9.83 Million | ▼ -15.8% |
| 2017 | -0.45x | $-3.85 Million | $8.60 Million | ▲ +41.0% |
| 2016 | -0.76x | $-5.00 Million | $6.58 Million | ▼ -44.3% |
| 2015 | -0.53x | $-3.12 Million | $5.93 Million | ▼ -40.1% |
| 2014 | -0.38x | $-3.23 Million | $8.58 Million | ▼ -13.6% |
| 2013 | -0.33x | $-2.67 Million | $8.07 Million | ▲ +33.3% |
| 2012 | -0.50x | $-3.18 Million | $6.41 Million | ▲ +30.9% |
| 2011 | -0.72x | $-2.81 Million | $3.91 Million | ▼ -19.6% |
| 2010 | -0.60x | $-729.22K | $1.21 Million | — |